Latest Insider Transactions at Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a real-time view of insider transactions for Catalyst Pharmaceuticals, Inc. (CPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2020
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+50.0%
|
-
|
|
Dec 22
2020
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.59%
|
-
|
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,571
-0.87%
|
-
|
|
Dec 22
2020
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,666
+3.45%
|
-
|
|
Sep 30
2020
|
Patrick J Mcenany Director |
BUY
Open market or private purchase
|
Direct |
15,000
+0.31%
|
$30,000
$2.97 P/Share
|
|
Sep 30
2020
|
Charles B O'Keeffe Director |
BUY
Open market or private purchase
|
Direct |
7,000
+1.23%
|
$14,000
$2.99 P/Share
|